skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Mechanism-based inactivator of isocitrate lyases 1 and 2 from Mycobacterium tuberculosis

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
 [1];  [2];  [3];  [4]; ORCiD logo [4]; ORCiD logo [5];  [1];  [6];  [1]
  1. Texas A & M Univ., College Station, TX (United States)
  2. Univ. at Buffalo, The State Univ. of New York, Buffalo, NY (United States)
  3. Univ. at Buffalo, The State Univ. of New York, Buffalo, NY (United States); Janssen Research and Development, Malvern, PA (United States)
  4. Victoria Univ. of Wellington (New Zealand)
  5. Texas A & M Univ., College Station, TX (United States); Fujifilm Diosynth Biotechnologies Texas, College Station, TX (United States)
  6. Texas A & M Univ., College Station, TX (United States); Albany Molecular Research, Inc., Albany, NY (United States)

Isocitrate lyase (ICL, types 1 and 2) is the first enzyme of the glyoxylate shunt, an essential pathway for Mycobacterium tuberculosis (Mtb) during the persistent phase of human TB infection. Here, we report 2-vinyl-d-isocitrate (2-VIC) as a mechanism-based inactivator of Mtb ICL1 and ICL2. The enzyme-catalyzed retro-aldol cleavage of 2-VIC unmasks a Michael substrate, 2-vinylglyoxylate, which then forms a slowly reversible, covalent adduct with the thiolate form of active-site Cys191. 2-VIC displayed kinetic properties consistent with covalent, mechanism-based inactivation of ICL1 and ICL2 with high efficiency (partition ratio, <1). As a result, analysis of a complex of ICL1:2-VIC by electrospray ionization mass spectrometry and X-ray crystallography confirmed the formation of the predicted covalent S-homopyruvoyl adduct of the active-site Cys191.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States)
Sponsoring Organization:
National Institutes of Health (NIH); Welch Foundation
Grant/Contract Number:
P011AI095208; A-0015
OSTI ID:
1390888
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Issue 29; ISSN 0027-8424
Publisher:
National Academy of SciencesCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 26 works
Citation information provided by
Web of Science

References (17)

Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence journal May 2005
Solvent Isotope-Induced Equilibrium Perturbation for Isocitrate Lyase journal November 2013
Use of Carbon Sources for Lipid Biosynthesis in Mycobacterium leprae: a Comparison with Other Pathogenic Mycobacteria journal August 1988
Cysteine Is the General Base That Serves in Catalysis by Isocitrate Lyase and in Mechanism-Based Inhibition by 3-Nitropropionate journal December 2013
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading journal January 2009
Inhibition of isocitrate lyase by 3-nitropropionate, a reaction-intermediate analog journal August 1982
Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids journal March 2014
Alkylation of isocitrate lyase from Escherichia coli by 3-bromopyruvate journal May 1990
Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis journal August 2006
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase journal August 2000
Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis journal October 2009
Prolonged and tunable residence time using reversible covalent kinase inhibitors journal May 2015
The resurgence of covalent drugs journal April 2011
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β- d -ribofuranose 2′-Oxidase DprE1 journal December 2011
Suicide Substrates, Mechanism-Based Enzyme Inactivators: Recent Developments journal June 1984
Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. journal January 1982
Suicide Substrates, Mechanism-Based Enzyme Inactivators: Recent Developments journal January 1984

Cited By (3)

Erratum: Mechanistic enzymology in drug discovery: a fresh perspective journal December 2017
Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2 journal October 2019
Mechanistic enzymology in drug discovery: a fresh perspective journal December 2017